|
OMIM |
Link |
Information gain |
01 |
|
CMD1H
|
[NCBI]
|
0.00152528
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.00152528
|
|
|
SCZD10
|
[NCBI]
|
0.0015049
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.0012951
|
|
|
DFNB5
|
[NCBI]
|
0.00116352
|
|
|
SHFLD2
|
[NCBI]
|
0.00116352
|
|
|
IDDM3
|
[NCBI]
|
0.00116352
|
|
|
CMD1F
|
[NCBI]
|
0.00116352
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.00100197
|
|
|
AUTS5
|
[NCBI]
|
0.000892184
|
|
|
CMD1B
|
[NCBI]
|
0.000892184
|
|
|
SPG12
|
[NCBI]
|
0.000892184
|
|
|
MMVP3
|
[NCBI]
|
0.000761971
|
|
|
MRT5
|
[NCBI]
|
0.000761971
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000761971
|
|
|
MRT11
|
[NCBI]
|
0.000761971
|
|
|
diamond-blackfan anemia 2
|
[NCBI]
|
0.000761971
|
|
|
high density lipoprotein deficiency 3
|
[NCBI]
|
0.000761971
|
|
|
RP23
|
[NCBI]
|
0.000761971
|
|
|
MRT10
|
[NCBI]
|
0.000761971
|
|
|
DFNA24
|
[NCBI]
|
0.000761971
|
|
|
asthma-related traits, susceptibility to, 4
|
[NCBI]
|
0.000761971
|
|
|
MRT9
|
[NCBI]
|
0.000761971
|
|
|
SCKL2
|
[NCBI]
|
0.000761971
|
|
|
PNKD2
|
[NCBI]
|
0.000761971
|
|
|
AUTS11
|
[NCBI]
|
0.000761971
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000761971
|
|
|
GLC1B
|
[NCBI]
|
0.000761971
|
|
|
MRT8
|
[NCBI]
|
0.000761971
|
|
|
SCKL3
|
[NCBI]
|
0.000761971
|
|
|
FEB6
|
[NCBI]
|
0.000761971
|
|
|
DFNA52
|
[NCBI]
|
0.000761971
|
|
|
ciliary dyskinesia, primary, 5
|
[NCBI]
|
0.000761971
|
|
|
MRT7
|
[NCBI]
|
0.000761971
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000761971
|
|
|
MAFD5
|
[NCBI]
|
0.000761971
|
|
|
FGS4
|
[NCBI]
|
0.000761971
|
|
|
synpolydactyly 3
|
[NCBI]
|
0.000761971
|
|
|
MMVP2
|
[NCBI]
|
0.000761971
|
|
|
ciliary dyskinesia, primary, 4
|
[NCBI]
|
0.000761971
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.000761971
|
|
|
AIS4
|
[NCBI]
|
0.000761971
|
|
|
SCZD3
|
[NCBI]
|
0.000761133
|
|
|
SPG5A
|
[NCBI]
|
0.000741891
|
|
|
VUR1
|
[NCBI]
|
0.000732708
|
|
|
SLE
|
[NCBI]
|
0.000730364
|
|
|
RA
|
[NCBI]
|
0.000715786
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000685994
|
|
|
IBD2
|
[NCBI]
|
0.000638157
|
|
|
HPCX
|
[NCBI]
|
0.000596443
|
|
|
glucocorticoid deficiency 3
|
[NCBI]
|
0.00050034
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.00050034
|
|
|
GLC3B
|
[NCBI]
|
0.00050034
|
|
|
epilepsy, myoclonic, benign adult familial, type 2
|
[NCBI]
|
0.00050034
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.00050034
|
|
|
MRT12
|
[NCBI]
|
0.00050034
|
|
|
thyroid carcinoma, nonmedullary 1
|
[NCBI]
|
0.00050034
|
|
|
PTLAH
|
[NCBI]
|
0.00050034
|
|
|
NNCI
|
[NCBI]
|
0.00050034
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.00050034
|
|
|
MPD3
|
[NCBI]
|
0.00050034
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.00050034
|
|
|
pyloric stenosis, infantile hypertrophic, 2
|
[NCBI]
|
0.00050034
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.00050034
|
|
|
HCFP2
|
[NCBI]
|
0.00050034
|
|
|
CMD1K
|
[NCBI]
|
0.00050034
|
|
|
migraine with or without aura, susceptibility to, 10
|
[NCBI]
|
0.00050034
|
|
|
DYX9
|
[NCBI]
|
0.00050034
|
|
|
IDDM8
|
[NCBI]
|
0.00050034
|
|
|
friedreich ataxia 2
|
[NCBI]
|
0.00050034
|
|
|
migraine with or without aura, susceptibility to, 11
|
[NCBI]
|
0.00050034
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.000403822
|
|
|
myasthenia gravis with thymus hyperplasia
|
[NCBI]
|
0.000403822
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.000403822
|
|
|
CMTX3
|
[NCBI]
|
0.000403822
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.000403822
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
0.000403822
|
|
|
EJM2
|
[NCBI]
|
0.000403822
|
|
|
neuropathy, hereditary motor and sensory, okinawa type
|
[NCBI]
|
0.000403822
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000403822
|
|
|
IDDM15
|
[NCBI]
|
0.000403822
|
|
|
SPG19
|
[NCBI]
|
0.000403822
|
|
|
OFC2
|
[NCBI]
|
0.000403822
|
|
|
macular dystrophy, butterfly-shaped pigmentary, 2
|
[NCBI]
|
0.000403822
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000403822
|
|
|
LI5
|
[NCBI]
|
0.000403822
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000403822
|
|
|
EVR3
|
[NCBI]
|
0.000342401
|
|
|
CNA1
|
[NCBI]
|
0.000342401
|
|
|
EXT3
|
[NCBI]
|
0.000342401
|
|
|
ARVD3
|
[NCBI]
|
0.000342401
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.000342401
|
|
|
ICCA
|
[NCBI]
|
0.000342401
|
|
|
LGMD1D
|
[NCBI]
|
0.000342401
|
|
|
DFNB15
|
[NCBI]
|
0.000342401
|
|
|
noonan syndrome 2
|
[NCBI]
|
0.000342401
|
|
|
SCA19
|
[NCBI]
|
0.000342401
|
|
|
ARVD5
|
[NCBI]
|
0.000342401
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.000342401
|
|
|
DYX6
|
[NCBI]
|
0.000342401
|
|
|
ARVD4
|
[NCBI]
|
0.000342401
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000297648
|
|
|
CMDR
|
[NCBI]
|
0.000297648
|
|
|
HBD
|
[NCBI]
|
0.000297648
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.000297648
|
|
|
OPA4
|
[NCBI]
|
0.000297648
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000297648
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000297648
|
|
|
MAFD1
|
[NCBI]
|
0.000273479
|
|
|
hemangioma, capillary infantile
|
[NCBI]
|
0.000262714
|
|
|
EKD2
|
[NCBI]
|
0.000262714
|
|
|
HCFP1
|
[NCBI]
|
0.000262714
|
|
|
vestibulopathy, familial
|
[NCBI]
|
0.000262714
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.000262714
|
|
|
keratosis palmoplantaris papulosa
|
[NCBI]
|
0.000262714
|
|
|
CNC2
|
[NCBI]
|
0.000262714
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000262714
|
|
|
HMN1
|
[NCBI]
|
0.000234268
|
|
|
omodysplasia, generalized form
|
[NCBI]
|
0.000234268
|
|
|
deafness, congenital, and onychodystrophy, recessive form
|
[NCBI]
|
0.000234268
|
|
|
ASD1
|
[NCBI]
|
0.000234268
|
|
|
SHFM2
|
[NCBI]
|
0.000234268
|
|
|
acetabular dysplasia
|
[NCBI]
|
0.000234268
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
0.000234268
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000234268
|
|
|
MNG1
|
[NCBI]
|
0.000234268
|
|
|
IS1
|
[NCBI]
|
0.000214393
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000210432
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
0.000210432
|
|
|
IDDM7
|
[NCBI]
|
0.000210432
|
|
|
CF
|
[NCBI]
|
0.000206294
|
|
|
ORW2
|
[NCBI]
|
0.000203835
|
|
|
CGL2
|
[NCBI]
|
0.000199617
|
|
|
CNC1
|
[NCBI]
|
0.000195624
|
|
|
SCZD7
|
[NCBI]
|
0.000190045
|
|
|
SCZD6
|
[NCBI]
|
0.000190045
|
|
|
SPG10
|
[NCBI]
|
0.000187631
|
|
|
PDB
|
[NCBI]
|
0.000184788
|
|
|
SPG17
|
[NCBI]
|
0.00018015
|
|
|
centralopathic epilepsy
|
[NCBI]
|
0.000172333
|
|
|
SHFLD1
|
[NCBI]
|
0.000172333
|
|
|
MCDC1
|
[NCBI]
|
0.000167605
|
|
|
prostate cancer
|
[NCBI]
|
0.000165352
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
0.000162905
|
|
|
SCZD9
|
[NCBI]
|
0.00015733
|
|
|
OTSC1
|
[NCBI]
|
0.00015676
|
|
|
AUTS6
|
[NCBI]
|
0.00015676
|
|
|
SHFM1
|
[NCBI]
|
0.000154764
|
|
|
GLC1A
|
[NCBI]
|
0.000150545
|
|
|
FSGS2
|
[NCBI]
|
0.000145747
|
|
|
HPC1
|
[NCBI]
|
0.000144748
|
|
|
PSORS2
|
[NCBI]
|
0.000142935
|
|
|
CMD1D
|
[NCBI]
|
0.00013401
|
|
|
EDM3
|
[NCBI]
|
0.00013401
|
|
|
IDDM4
|
[NCBI]
|
0.000130564
|
|
|
MRD
|
[NCBI]
|
0.000130564
|
|
|
IBGC1
|
[NCBI]
|
0.000130564
|
|
|
CRC
|
[NCBI]
|
0.00013037
|
|
|
MLC
|
[NCBI]
|
0.000125832
|
|
|
CMD1E
|
[NCBI]
|
0.000125046
|
|
|
FSGS1
|
[NCBI]
|
0.00011779
|
|
|
EJM1
|
[NCBI]
|
0.00011779
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
0.000111697
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
0.000111697
|
|
|
PJS
|
[NCBI]
|
0.000110027
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
0.000107857
|
|
|
EDM4
|
[NCBI]
|
0.000106447
|
|
|
SPG11
|
[NCBI]
|
0.000106447
|
|
|
HFE3
|
[NCBI]
|
0.000106447
|
|
|
SPG3A
|
[NCBI]
|
0.000104177
|
|
|
SPG4
|
[NCBI]
|
0.00010243
|
|
|
BRIC1
|
[NCBI]
|
0.000101838
|
|
|
MCPH5
|
[NCBI]
|
0.000101838
|
|
|
HFE4
|
[NCBI]
|
0.000101838
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
0.000101838
|
|
|
immotile cilia syndrome due to excessively long cilia
|
[NCBI]
|
0.000100494
|
|
|
ectodermal dysplasia, trichoodontoonychial type
|
[NCBI]
|
0.000100494
|
|
|
pelviscapular dysplasia
|
[NCBI]
|
0.000100494
|
|
|
metaphyseal anadysplasia
|
[NCBI]
|
0.000100494
|
|
|
oculomaxillofacial dysplasia with oblique facial clefts
|
[NCBI]
|
0.000100494
|
|
|
mandibulofacial dysostosis with ptosis, autosomal dominant
|
[NCBI]
|
0.000100494
|
|
|
spastic paraplegia, optic atrophy, microcephaly, and xy sex reversal
|
[NCBI]
|
0.000100494
|
|
|
PCD
|
[NCBI]
|
0.000100244
|
|
|
IGAD1
|
[NCBI]
|
0.000100169
|
|
|
brody myopathy
|
[NCBI]
|
9.77335e-05
|
|
|
SPG6
|
[NCBI]
|
9.77335e-05
|
|
|
BDA1
|
[NCBI]
|
9.77335e-05
|
|
|
BTHS
|
[NCBI]
|
9.44866e-05
|
|
|
SMEI
|
[NCBI]
|
9.30366e-05
|
|
|
EIG
|
[NCBI]
|
9.22442e-05
|
|
|
RSTS
|
[NCBI]
|
9.16273e-05
|
|
|
ARH
|
[NCBI]
|
9.06733e-05
|
|
|
EDM1
|
[NCBI]
|
9.06733e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
9.06733e-05
|
|
|
CMD3B
|
[NCBI]
|
9.06733e-05
|
|
|
LWD
|
[NCBI]
|
8.51239e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
8.475e-05
|
|
|
JH
|
[NCBI]
|
8.475e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
8.475e-05
|
|
|
SHFM3
|
[NCBI]
|
8.41308e-05
|
|
|
IGAN1
|
[NCBI]
|
8.41308e-05
|
|
|
ATD1
|
[NCBI]
|
8.41308e-05
|
|
|
CDAN2
|
[NCBI]
|
8.41308e-05
|
|
|
MG
|
[NCBI]
|
8.23869e-05
|
|
|
PARK6
|
[NCBI]
|
8.2114e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
8.2114e-05
|
|
|
HHT
|
[NCBI]
|
8.15994e-05
|
|
|
ICP
|
[NCBI]
|
7.96573e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
7.7358e-05
|
|
|
EAOH
|
[NCBI]
|
7.7358e-05
|
|
|
TTDP
|
[NCBI]
|
7.51981e-05
|
|
|
BPES
|
[NCBI]
|
7.42632e-05
|
|
|
WFS2
|
[NCBI]
|
7.28528e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
7.28528e-05
|
|
|
MRX93
|
[NCBI]
|
7.28528e-05
|
|
|
CCA3
|
[NCBI]
|
7.28528e-05
|
|
|
ASD2
|
[NCBI]
|
7.28528e-05
|
|
|
MCPH3
|
[NCBI]
|
7.28528e-05
|
|
|
MRT6
|
[NCBI]
|
7.28528e-05
|
|
|
SPG5B
|
[NCBI]
|
7.28528e-05
|
|
|
MCOPS8
|
[NCBI]
|
7.28528e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
7.12383e-05
|
|
|
UCMD
|
[NCBI]
|
7.12383e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
7.10431e-05
|
|
|
JBTS1
|
[NCBI]
|
7.06116e-05
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
6.94147e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
6.94147e-05
|
|
|
EKV
|
[NCBI]
|
6.76822e-05
|
|
|
HNFJ
|
[NCBI]
|
6.29557e-05
|
|
|
CMD1J
|
[NCBI]
|
6.25029e-05
|
|
|
SCA11
|
[NCBI]
|
6.25029e-05
|
|
|
PEOA4
|
[NCBI]
|
6.25029e-05
|
|
|
CMD3A
|
[NCBI]
|
6.25029e-05
|
|
|
FEB4
|
[NCBI]
|
6.25029e-05
|
|
|
SMC
|
[NCBI]
|
6.25029e-05
|
|
|
split-foot deformity with mandibulofacial dysostosis
|
[NCBI]
|
6.25029e-05
|
|
|
pelvis-shoulder dysplasia
|
[NCBI]
|
6.25029e-05
|
|
|
BOS3
|
[NCBI]
|
6.25029e-05
|
|
|
EFHC1
|
[NCBI]
|
6.14177e-05
|
|
|
HPS
|
[NCBI]
|
6.10374e-05
|
|
|
RP
|
[NCBI]
|
6.07028e-05
|
|
|
AD
|
[NCBI]
|
6.04226e-05
|
|
|
TNF
|
[NCBI]
|
5.92876e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.67266e-05
|
|
|
RBS
|
[NCBI]
|
5.63115e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
5.58283e-05
|
|
|
CMD1C
|
[NCBI]
|
5.58283e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
5.58283e-05
|
|
|
CMD1G
|
[NCBI]
|
5.58283e-05
|
|
|
hereditary motor and sensory neuropathy vi
|
[NCBI]
|
5.58283e-05
|
|
|
LI3
|
[NCBI]
|
5.58283e-05
|
|
|
SCA15
|
[NCBI]
|
5.58283e-05
|
|
|
cardiomyopathy, dilated, autosomal recessive
|
[NCBI]
|
5.58283e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
5.58283e-05
|
|
|
CCL
|
[NCBI]
|
5.58283e-05
|
|
|
EBN2
|
[NCBI]
|
5.58283e-05
|
|
|
SPG4
|
[NCBI]
|
5.57157e-05
|
|
|
GJB4
|
[NCBI]
|
5.52087e-05
|
|
|
CHST6
|
[NCBI]
|
5.52087e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
5.51301e-05
|
|
|
cystinuria
|
[NCBI]
|
5.51301e-05
|
|
|
MYO7A
|
[NCBI]
|
5.47263e-05
|
|
|
EEC1
|
[NCBI]
|
5.40158e-05
|
|
|
LGMD2A
|
[NCBI]
|
5.39905e-05
|
|
|
EVA
|
[NCBI]
|
5.289e-05
|
|
|
HCH
|
[NCBI]
|
5.289e-05
|
|
|
BRCA1
|
[NCBI]
|
5.26151e-05
|
|
|
RP15
|
[NCBI]
|
5.08993e-05
|
|
|
RCDP3
|
[NCBI]
|
5.08993e-05
|
|
|
muscle glycogenosis, x-linked
|
[NCBI]
|
5.08993e-05
|
|
|
CACP
|
[NCBI]
|
5.08993e-05
|
|
|
EDM2
|
[NCBI]
|
5.08993e-05
|
|
|
PFIC2
|
[NCBI]
|
5.08993e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
5.08993e-05
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
5.08993e-05
|
|
|
DFNB12
|
[NCBI]
|
5.08993e-05
|
|
|
DFNA13
|
[NCBI]
|
5.08993e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
5.08993e-05
|
|
|
MKS3
|
[NCBI]
|
5.08993e-05
|
|
|
PDB1
|
[NCBI]
|
5.08993e-05
|
|
|
WFS1
|
[NCBI]
|
5.07975e-05
|
|
|
CDKN2A
|
[NCBI]
|
5.06549e-05
|
|
|
COH1
|
[NCBI]
|
4.98014e-05
|
|
|
autism
|
[NCBI]
|
4.94364e-05
|
|
|
RP2
|
[NCBI]
|
4.90482e-05
|
|
|
HHF1
|
[NCBI]
|
4.79003e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
4.69984e-05
|
|
|
DFNB7
|
[NCBI]
|
4.69984e-05
|
|
|
SPG13
|
[NCBI]
|
4.69984e-05
|
|
|
EVR4
|
[NCBI]
|
4.69984e-05
|
|
|
ARVD2
|
[NCBI]
|
4.69984e-05
|
|
|
SHFM4
|
[NCBI]
|
4.69984e-05
|
|
|
CGL1
|
[NCBI]
|
4.69984e-05
|
|
|
CINCA
|
[NCBI]
|
4.69984e-05
|
|
|
elejalde disease
|
[NCBI]
|
4.69984e-05
|
|
|
naxos disease
|
[NCBI]
|
4.69984e-05
|
|
|
DFNA11
|
[NCBI]
|
4.69984e-05
|
|
|
USH2C
|
[NCBI]
|
4.69984e-05
|
|
|
POAG
|
[NCBI]
|
4.69922e-05
|
|
|
FGD1
|
[NCBI]
|
4.69432e-05
|
|
|
DBA
|
[NCBI]
|
4.59864e-05
|
|
|
MLC1
|
[NCBI]
|
4.58142e-05
|
|
|
C10ORF2
|
[NCBI]
|
4.58142e-05
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
4.49149e-05
|
|
|
LI1
|
[NCBI]
|
4.4421e-05
|
|
|
JPS
|
[NCBI]
|
4.4421e-05
|
|
|
KCNJ1
|
[NCBI]
|
4.38388e-05
|
|
|
G6PD
|
[NCBI]
|
4.38327e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
4.37768e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
4.37768e-05
|
|
|
KNO
|
[NCBI]
|
4.37768e-05
|
|
|
cataract-microcornea syndrome
|
[NCBI]
|
4.37768e-05
|
|
|
HMS
|
[NCBI]
|
4.37768e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
4.37768e-05
|
|
|
STHAG3
|
[NCBI]
|
4.37768e-05
|
|
|
SPMM
|
[NCBI]
|
4.37768e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
4.37768e-05
|
|
|
SCA5
|
[NCBI]
|
4.37768e-05
|
|
|
pneumothorax, primary spontaneous
|
[NCBI]
|
4.37768e-05
|
|
|
FHL2
|
[NCBI]
|
4.37768e-05
|
|
|
SQT1
|
[NCBI]
|
4.37768e-05
|
|
|
DRD4
|
[NCBI]
|
4.27797e-05
|
|
|
LDLR
|
[NCBI]
|
4.26546e-05
|
|
|
SPG3A
|
[NCBI]
|
4.21502e-05
|
|
|
SGSH
|
[NCBI]
|
4.21502e-05
|
|
|
RYR1
|
[NCBI]
|
4.16317e-05
|
|
|
PANK2
|
[NCBI]
|
4.13897e-05
|
|
|
mal de meleda
|
[NCBI]
|
4.1038e-05
|
|
|
short syndrome
|
[NCBI]
|
4.1038e-05
|
|
|
GS1
|
[NCBI]
|
4.1038e-05
|
|
|
opitz syndrome
|
[NCBI]
|
4.1038e-05
|
|
|
PHA2
|
[NCBI]
|
4.1038e-05
|
|
|
vitiligo
|
[NCBI]
|
4.1038e-05
|
|
|
SANDO
|
[NCBI]
|
4.1038e-05
|
|
|
PARK7
|
[NCBI]
|
4.1038e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
4.1038e-05
|
|
|
MRX9
|
[NCBI]
|
4.1038e-05
|
|
|
EPD
|
[NCBI]
|
4.1038e-05
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
4.1038e-05
|
|
|
IBMPFD
|
[NCBI]
|
4.1038e-05
|
|
|
MCOPS2
|
[NCBI]
|
4.1038e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
4.08578e-05
|
|
|
ACTC1
|
[NCBI]
|
3.93682e-05
|
|
|
GUCY2D
|
[NCBI]
|
3.93682e-05
|
|
|
HHF2
|
[NCBI]
|
3.9174e-05
|
|
|
FCMD
|
[NCBI]
|
3.9174e-05
|
|
|
GS2
|
[NCBI]
|
3.86603e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
3.86603e-05
|
|
|
INAD1
|
[NCBI]
|
3.86603e-05
|
|
|
CMT4B2
|
[NCBI]
|
3.86603e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
3.86603e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
3.86603e-05
|
|
|
CMT2D
|
[NCBI]
|
3.86603e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
3.86603e-05
|
|
|
ADHR
|
[NCBI]
|
3.86603e-05
|
|
|
SCA7
|
[NCBI]
|
3.84973e-05
|
|
|
CLS
|
[NCBI]
|
3.84973e-05
|
|
|
BWS
|
[NCBI]
|
3.81557e-05
|
|
|
phenylketonuria
|
[NCBI]
|
3.77632e-05
|
|
|
FA
|
[NCBI]
|
3.72985e-05
|
|
|
BBS
|
[NCBI]
|
3.7213e-05
|
|
|
MTM1
|
[NCBI]
|
3.71915e-05
|
|
|
GJB3
|
[NCBI]
|
3.71272e-05
|
|
|
LMNA
|
[NCBI]
|
3.68536e-05
|
|
|
CDH23
|
[NCBI]
|
3.6629e-05
|
|
|
PARK1
|
[NCBI]
|
3.65628e-05
|
|
|
argininemia
|
[NCBI]
|
3.65628e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
3.65628e-05
|
|
|
PKD3
|
[NCBI]
|
3.65628e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
3.65628e-05
|
|
|
LGMD2E
|
[NCBI]
|
3.65628e-05
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
3.65628e-05
|
|
|
USH1D
|
[NCBI]
|
3.65628e-05
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
3.65628e-05
|
|
|
LQT1
|
[NCBI]
|
3.47536e-05
|
|
|
BDC
|
[NCBI]
|
3.46892e-05
|
|
|
ASMD
|
[NCBI]
|
3.46892e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
3.46892e-05
|
|
|
BDB1
|
[NCBI]
|
3.46892e-05
|
|
|
scheie syndrome
|
[NCBI]
|
3.46892e-05
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
3.46892e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
3.46892e-05
|
|
|
DFNA12
|
[NCBI]
|
3.46892e-05
|
|
|
OCD1
|
[NCBI]
|
3.46892e-05
|
|
|
FGFR3
|
[NCBI]
|
3.46613e-05
|
|
|
COL17A1
|
[NCBI]
|
3.44188e-05
|
|
|
KCNJ11
|
[NCBI]
|
3.3642e-05
|
|
|
PTPN11
|
[NCBI]
|
3.32726e-05
|
|
|
SLC40A1
|
[NCBI]
|
3.32726e-05
|
|
|
MERRF
|
[NCBI]
|
3.29985e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
3.29985e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
3.29985e-05
|
|
|
CLN5
|
[NCBI]
|
3.29985e-05
|
|
|
CYLD
|
[NCBI]
|
3.29985e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
3.29985e-05
|
|
|
CMT2B
|
[NCBI]
|
3.29985e-05
|
|
|
IHPS1
|
[NCBI]
|
3.29985e-05
|
|
|
RPS6KA3
|
[NCBI]
|
3.15872e-05
|
|
|
LDS
|
[NCBI]
|
3.14602e-05
|
|
|
adult syndrome
|
[NCBI]
|
3.14602e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
3.14602e-05
|
|
|
KFSD
|
[NCBI]
|
3.14602e-05
|
|
|
NCIE1
|
[NCBI]
|
3.14602e-05
|
|
|
GK
|
[NCBI]
|
3.12784e-05
|
|
|
MODY
|
[NCBI]
|
3.12548e-05
|
|
|
SHOX
|
[NCBI]
|
3.09777e-05
|
|
|
STK11IP
|
[NCBI]
|
3.07003e-05
|
|
|
dynein, axonemal, intermediate chain 2
|
[NCBI]
|
3.07003e-05
|
|
|
GPR92
|
[NCBI]
|
3.07003e-05
|
|
|
ZNF79
|
[NCBI]
|
3.07003e-05
|
|
|
WISP2
|
[NCBI]
|
3.07003e-05
|
|
|
NUDT4
|
[NCBI]
|
3.07003e-05
|
|
|
STK11
|
[NCBI]
|
3.03996e-05
|
|
|
holoprosencephaly
|
[NCBI]
|
3.03715e-05
|
|
|
LQT3
|
[NCBI]
|
3.00507e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
3.00507e-05
|
|
|
GCCD1
|
[NCBI]
|
3.00507e-05
|
|
|
CORDX1
|
[NCBI]
|
3.00507e-05
|
|
|
JME
|
[NCBI]
|
3.00507e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
3.00507e-05
|
|
|
AGS1
|
[NCBI]
|
3.00507e-05
|
|
|
CDS
|
[NCBI]
|
3.00507e-05
|
|
|
CFEOM1
|
[NCBI]
|
3.00507e-05
|
|
|
STGD3
|
[NCBI]
|
3.00507e-05
|
|
|
HMN5
|
[NCBI]
|
3.00507e-05
|
|
|
JLNS1
|
[NCBI]
|
3.00507e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
2.98498e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
2.90298e-05
|
|
|
FGFR2
|
[NCBI]
|
2.88374e-05
|
|
|
GAN1
|
[NCBI]
|
2.87516e-05
|
|
|
ADLTE
|
[NCBI]
|
2.87516e-05
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
2.87516e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
2.87516e-05
|
|
|
MCPH1
|
[NCBI]
|
2.87516e-05
|
|
|
SCZD4
|
[NCBI]
|
2.87516e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
2.87516e-05
|
|
|
DNAI1
|
[NCBI]
|
2.75959e-05
|
|
|
TTBK2
|
[NCBI]
|
2.75959e-05
|
|
|
SYN3
|
[NCBI]
|
2.75959e-05
|
|
|
PTPRH
|
[NCBI]
|
2.75959e-05
|
|
|
TMEM67
|
[NCBI]
|
2.75959e-05
|
|
|
CNO
|
[NCBI]
|
2.75959e-05
|
|
|
EVER2
|
[NCBI]
|
2.75959e-05
|
|
|
MKS1
|
[NCBI]
|
2.75959e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
2.75482e-05
|
|
|
NBIA1
|
[NCBI]
|
2.75482e-05
|
|
|
PFIC1
|
[NCBI]
|
2.75482e-05
|
|
|
IPEX
|
[NCBI]
|
2.75482e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
2.75482e-05
|
|
|
SDS
|
[NCBI]
|
2.72381e-05
|
|
|
RLBP1
|
[NCBI]
|
2.72328e-05
|
|
|
MYH7
|
[NCBI]
|
2.68171e-05
|
|
|
CFTR
|
[NCBI]
|
2.66749e-05
|
|
|
HFE
|
[NCBI]
|
2.66244e-05
|
|
|
DYX2
|
[NCBI]
|
2.64284e-05
|
|
|
SCCMS
|
[NCBI]
|
2.64284e-05
|
|
|
refsum disease
|
[NCBI]
|
2.64284e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
2.64284e-05
|
|
|
DHRD
|
[NCBI]
|
2.64284e-05
|
|
|
alkaptonuria
|
[NCBI]
|
2.64284e-05
|
|
|
NPHS1
|
[NCBI]
|
2.64284e-05
|
|
|
CIPA
|
[NCBI]
|
2.64284e-05
|
|
|
AHDS
|
[NCBI]
|
2.64284e-05
|
|
|
ANGPTL2
|
[NCBI]
|
2.55828e-05
|
|
|
UNG2
|
[NCBI]
|
2.55828e-05
|
|
|
SNX3
|
[NCBI]
|
2.55828e-05
|
|
|
HPS3
|
[NCBI]
|
2.55828e-05
|
|
|
CLN5
|
[NCBI]
|
2.55828e-05
|
|
|
CRELD1
|
[NCBI]
|
2.55828e-05
|
|
|
RPL12
|
[NCBI]
|
2.55828e-05
|
|
|
EFEMP2
|
[NCBI]
|
2.55828e-05
|
|
|
EVER1
|
[NCBI]
|
2.55828e-05
|
|
|
GAN
|
[NCBI]
|
2.55828e-05
|
|
|
PSORS1
|
[NCBI]
|
2.55739e-05
|
|
|
ABS
|
[NCBI]
|
2.53824e-05
|
|
|
GABEB
|
[NCBI]
|
2.53824e-05
|
|
|
FHM2
|
[NCBI]
|
2.53824e-05
|
|
|
BGS
|
[NCBI]
|
2.53824e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
2.53824e-05
|
|
|
NS1
|
[NCBI]
|
2.51762e-05
|
|
|
HIDS
|
[NCBI]
|
2.44019e-05
|
|
|
EBN1
|
[NCBI]
|
2.44019e-05
|
|
|
CBAVD
|
[NCBI]
|
2.44019e-05
|
|
|
CLN2
|
[NCBI]
|
2.44019e-05
|
|
|
GEFS+
|
[NCBI]
|
2.44019e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
2.44019e-05
|
|
|
MMP20
|
[NCBI]
|
2.40881e-05
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
2.40881e-05
|
|
|
PDE6A
|
[NCBI]
|
2.40881e-05
|
|
|
NYX
|
[NCBI]
|
2.40881e-05
|
|
|
CDK5RAP2
|
[NCBI]
|
2.40881e-05
|
|
|
SCA10
|
[NCBI]
|
2.34802e-05
|
|
|
PLOSL
|
[NCBI]
|
2.34802e-05
|
|
|
HEPOD
|
[NCBI]
|
2.34802e-05
|
|
|
AAA
|
[NCBI]
|
2.34802e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
2.34802e-05
|
|
|
PARK2
|
[NCBI]
|
2.32065e-05
|
|
|
CVID
|
[NCBI]
|
2.32e-05
|
|
|
DLX3
|
[NCBI]
|
2.28987e-05
|
|
|
SBF2
|
[NCBI]
|
2.28987e-05
|
|
|
MTTF
|
[NCBI]
|
2.28987e-05
|
|
|
HTR3A
|
[NCBI]
|
2.28987e-05
|
|
|
GTF2H5
|
[NCBI]
|
2.28987e-05
|
|
|
ANKK1
|
[NCBI]
|
2.28987e-05
|
|
|
COH1
|
[NCBI]
|
2.28987e-05
|
|
|
DNAH9
|
[NCBI]
|
2.28987e-05
|
|
|
PLUNC
|
[NCBI]
|
2.28987e-05
|
|
|
IDUA
|
[NCBI]
|
2.2638e-05
|
|
|
SNCA
|
[NCBI]
|
2.2638e-05
|
|
|
NHS
|
[NCBI]
|
2.26112e-05
|
|
|
GLC3A
|
[NCBI]
|
2.26112e-05
|
|
|
SLURP1
|
[NCBI]
|
2.1911e-05
|
|
|
NHS
|
[NCBI]
|
2.1911e-05
|
|
|
CLN2
|
[NCBI]
|
2.1911e-05
|
|
|
CHRNB1
|
[NCBI]
|
2.1911e-05
|
|
|
S100A9
|
[NCBI]
|
2.1911e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
2.179e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
2.179e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
2.179e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
2.179e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
2.12165e-05
|
|
|
PTGFR
|
[NCBI]
|
2.10667e-05
|
|
|
COL9A3
|
[NCBI]
|
2.10667e-05
|
|
|
NIPBL
|
[NCBI]
|
2.10667e-05
|
|
|
HADHB
|
[NCBI]
|
2.10667e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
2.10122e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
2.10122e-05
|
|
|
CSNB1A
|
[NCBI]
|
2.10122e-05
|
|
|
USH2A
|
[NCBI]
|
2.10122e-05
|
|
|
CLN1
|
[NCBI]
|
2.10122e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
2.10122e-05
|
|
|
CLCNKB
|
[NCBI]
|
2.03297e-05
|
|
|
CYSLTR1
|
[NCBI]
|
2.03297e-05
|
|
|
CHRND
|
[NCBI]
|
2.03297e-05
|
|
|
COL9A2
|
[NCBI]
|
2.03297e-05
|
|
|
SLC2A8
|
[NCBI]
|
2.03297e-05
|
|
|
heat-shock protein, 75-kd
|
[NCBI]
|
2.03297e-05
|
|
|
BSCL2
|
[NCBI]
|
2.03297e-05
|
|
|
CMM2
|
[NCBI]
|
2.02741e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
2.02741e-05
|
|
|
SCDO1
|
[NCBI]
|
2.02741e-05
|
|
|
HOKPP
|
[NCBI]
|
2.02741e-05
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
2.02741e-05
|
|
|
NPY
|
[NCBI]
|
2.00207e-05
|
|
|
TRPC6
|
[NCBI]
|
1.96758e-05
|
|
|
ATP8B1
|
[NCBI]
|
1.96758e-05
|
|
|
GSTT1
|
[NCBI]
|
1.96758e-05
|
|
|
MLPH
|
[NCBI]
|
1.96758e-05
|
|
|
GBE1
|
[NCBI]
|
1.96758e-05
|
|
|
PHKA1
|
[NCBI]
|
1.96758e-05
|
|
|
LMAN1
|
[NCBI]
|
1.96758e-05
|
|
|
CD
|
[NCBI]
|
1.96488e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
1.96433e-05
|
|
|
NEM3
|
[NCBI]
|
1.95723e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
1.95723e-05
|
|
|
MYOC
|
[NCBI]
|
1.93437e-05
|
|
|
CYLD1
|
[NCBI]
|
1.90884e-05
|
|
|
TYROBP
|
[NCBI]
|
1.90884e-05
|
|
|
STXBP1
|
[NCBI]
|
1.90884e-05
|
|
|
MDM1
|
[NCBI]
|
1.90884e-05
|
|
|
AMN
|
[NCBI]
|
1.90884e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
1.89039e-05
|
|
|
LCA1
|
[NCBI]
|
1.89039e-05
|
|
|
FBN1
|
[NCBI]
|
1.88527e-05
|
|
|
HPS1
|
[NCBI]
|
1.85554e-05
|
|
|
ARG1
|
[NCBI]
|
1.85554e-05
|
|
|
NLRP3
|
[NCBI]
|
1.85554e-05
|
|
|
PAX9
|
[NCBI]
|
1.85554e-05
|
|
|
PON2
|
[NCBI]
|
1.85554e-05
|
|
|
BFSP2
|
[NCBI]
|
1.85554e-05
|
|
|
ASPM
|
[NCBI]
|
1.85554e-05
|
|
|
FLCN
|
[NCBI]
|
1.85554e-05
|
|
|
ABCC8
|
[NCBI]
|
1.84764e-05
|
|
|
EVC
|
[NCBI]
|
1.82663e-05
|
|
|
OKS
|
[NCBI]
|
1.82663e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
1.82663e-05
|
|
|
DFNB1
|
[NCBI]
|
1.82663e-05
|
|
|
MATN3
|
[NCBI]
|
1.80675e-05
|
|
|
COL6A3
|
[NCBI]
|
1.80675e-05
|
|
|
ATP2A1
|
[NCBI]
|
1.80675e-05
|
|
|
LTA4H
|
[NCBI]
|
1.80675e-05
|
|
|
CHRNB2
|
[NCBI]
|
1.80675e-05
|
|
|
ART4
|
[NCBI]
|
1.80675e-05
|
|
|
SGCD
|
[NCBI]
|
1.80675e-05
|
|
|
MAPT
|
[NCBI]
|
1.7764e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.76573e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.76573e-05
|
|
|
AIMAH
|
[NCBI]
|
1.76573e-05
|
|
|
GARS
|
[NCBI]
|
1.7618e-05
|
|
|
COL9A1
|
[NCBI]
|
1.7618e-05
|
|
|
ATXN2
|
[NCBI]
|
1.7618e-05
|
|
|
TPM1
|
[NCBI]
|
1.7618e-05
|
|
|
HGD
|
[NCBI]
|
1.7618e-05
|
|
|
LDLRAP1
|
[NCBI]
|
1.7618e-05
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
1.74463e-05
|
|
|
EPM2A
|
[NCBI]
|
1.72012e-05
|
|
|
PRX
|
[NCBI]
|
1.72012e-05
|
|
|
S100A8
|
[NCBI]
|
1.72012e-05
|
|
|
SCN2A
|
[NCBI]
|
1.72012e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
1.70749e-05
|
|
|
FGFR1
|
[NCBI]
|
1.70198e-05
|
|
|
NAGLU
|
[NCBI]
|
1.68128e-05
|
|
|
RAB27A
|
[NCBI]
|
1.68128e-05
|
|
|
AGL
|
[NCBI]
|
1.68128e-05
|
|
|
oncogene dj1
|
[NCBI]
|
1.68128e-05
|
|
|
COL18A1
|
[NCBI]
|
1.64493e-05
|
|
|
COL5A1
|
[NCBI]
|
1.64493e-05
|
|
|
ALOX5
|
[NCBI]
|
1.64493e-05
|
|
|
NPHS1
|
[NCBI]
|
1.64493e-05
|
|
|
SLC26A2
|
[NCBI]
|
1.64493e-05
|
|
|
SLC19A1
|
[NCBI]
|
1.64493e-05
|
|
|
CRYBB2
|
[NCBI]
|
1.64493e-05
|
|
|
KEAP1
|
[NCBI]
|
1.64493e-05
|
|
|
FRDA
|
[NCBI]
|
1.63327e-05
|
|
|
ROR2
|
[NCBI]
|
1.61077e-05
|
|
|
MAN2B1
|
[NCBI]
|
1.61077e-05
|
|
|
NSD1
|
[NCBI]
|
1.61077e-05
|
|
|
KEL
|
[NCBI]
|
1.61077e-05
|
|
|
SQSTM1
|
[NCBI]
|
1.57855e-05
|
|
|
LMX1B
|
[NCBI]
|
1.54808e-05
|
|
|
HADHA
|
[NCBI]
|
1.54808e-05
|
|
|
FOXL2
|
[NCBI]
|
1.54808e-05
|
|
|
FLT4
|
[NCBI]
|
1.54808e-05
|
|
|
EP300
|
[NCBI]
|
1.54808e-05
|
|
|
SGCE
|
[NCBI]
|
1.54808e-05
|
|
|
PTEN
|
[NCBI]
|
1.54785e-05
|
|
|
FCHL
|
[NCBI]
|
1.54692e-05
|
|
|
TS
|
[NCBI]
|
1.53375e-05
|
|
|
PWS
|
[NCBI]
|
1.52583e-05
|
|
|
PCNA
|
[NCBI]
|
1.52117e-05
|
|
|
C9
|
[NCBI]
|
1.51917e-05
|
|
|
WNK1
|
[NCBI]
|
1.51917e-05
|
|
|
PHOX2B
|
[NCBI]
|
1.51917e-05
|
|
|
AMELX
|
[NCBI]
|
1.51917e-05
|
|
|
PARK2
|
[NCBI]
|
1.49762e-05
|
|
|
PGL1
|
[NCBI]
|
1.49762e-05
|
|
|
DRD3
|
[NCBI]
|
1.49169e-05
|
|
|
CUBN
|
[NCBI]
|
1.49169e-05
|
|
|
PEX7
|
[NCBI]
|
1.49169e-05
|
|
|
CHRNA1
|
[NCBI]
|
1.49169e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.46549e-05
|
|
|
GATA4
|
[NCBI]
|
1.46549e-05
|
|
|
LRE1
|
[NCBI]
|
1.46549e-05
|
|
|
SLC5A5
|
[NCBI]
|
1.46549e-05
|
|
|
MC2R
|
[NCBI]
|
1.46549e-05
|
|
|
CMD1A
|
[NCBI]
|
1.45022e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
1.45022e-05
|
|
|
LAMB3
|
[NCBI]
|
1.44047e-05
|
|
|
SDHD
|
[NCBI]
|
1.44047e-05
|
|
|
ATR
|
[NCBI]
|
1.44047e-05
|
|
|
CYP1B1
|
[NCBI]
|
1.44047e-05
|
|
|
apc gene
|
[NCBI]
|
1.43326e-05
|
|
|
TH
|
[NCBI]
|
1.4276e-05
|
|
|
HSR
|
[NCBI]
|
1.41653e-05
|
|
|
HNF1B
|
[NCBI]
|
1.41653e-05
|
|
|
PINK1
|
[NCBI]
|
1.41653e-05
|
|
|
MFN2
|
[NCBI]
|
1.41653e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.41653e-05
|
|
|
AVP
|
[NCBI]
|
1.41371e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
1.40461e-05
|
|
|
SJS1
|
[NCBI]
|
1.40461e-05
|
|
|
FCAS
|
[NCBI]
|
1.40461e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
1.40461e-05
|
|
|
CADASIL
|
[NCBI]
|
1.40461e-05
|
|
|
PCTT
|
[NCBI]
|
1.40461e-05
|
|
|
MYO5A
|
[NCBI]
|
1.39358e-05
|
|
|
KLF6
|
[NCBI]
|
1.39358e-05
|
|
|
LRP5
|
[NCBI]
|
1.39358e-05
|
|
|
NKX2E
|
[NCBI]
|
1.39358e-05
|
|
|
SLC3A1
|
[NCBI]
|
1.39358e-05
|
|
|
EXT1
|
[NCBI]
|
1.37154e-05
|
|
|
CACNA1C
|
[NCBI]
|
1.37154e-05
|
|
|
MTM1
|
[NCBI]
|
1.37154e-05
|
|
|
CDKN1C
|
[NCBI]
|
1.37154e-05
|
|
|
HEMB
|
[NCBI]
|
1.36969e-05
|
|
|
OPA1
|
[NCBI]
|
1.36068e-05
|
|
|
MEB
|
[NCBI]
|
1.36068e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
1.35559e-05
|
|
|
COL4A3
|
[NCBI]
|
1.35036e-05
|
|
|
GSTM1
|
[NCBI]
|
1.35036e-05
|
|
|
GJB2
|
[NCBI]
|
1.33683e-05
|
|
|
PRKAR1A
|
[NCBI]
|
1.32996e-05
|
|
|
CHRNE
|
[NCBI]
|
1.32996e-05
|
|
|
TNNT2
|
[NCBI]
|
1.32996e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.31834e-05
|
|
|
CDG1A
|
[NCBI]
|
1.31834e-05
|
|
|
PRSS1
|
[NCBI]
|
1.3103e-05
|
|
|
ARSB
|
[NCBI]
|
1.3103e-05
|
|
|
GSTP1
|
[NCBI]
|
1.29132e-05
|
|
|
PDS
|
[NCBI]
|
1.27751e-05
|
|
|
CST3
|
[NCBI]
|
1.27298e-05
|
|
|
TWIST1
|
[NCBI]
|
1.27298e-05
|
|
|
ERCC2
|
[NCBI]
|
1.25524e-05
|
|
|
CAPN3
|
[NCBI]
|
1.25524e-05
|
|
|
ALPL
|
[NCBI]
|
1.25524e-05
|
|
|
MEFV
|
[NCBI]
|
1.25524e-05
|
|
|
GCH1
|
[NCBI]
|
1.25524e-05
|
|
|
MTRNR1
|
[NCBI]
|
1.25524e-05
|
|
|
RECQL3
|
[NCBI]
|
1.23806e-05
|
|
|
DNMT3B
|
[NCBI]
|
1.22141e-05
|
|
|
EWSR1
|
[NCBI]
|
1.22141e-05
|
|
|
CYBB
|
[NCBI]
|
1.22141e-05
|
|
|
MFS
|
[NCBI]
|
1.21631e-05
|
|
|
PPOX
|
[NCBI]
|
1.20527e-05
|
|
|
MTS
|
[NCBI]
|
1.20005e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
1.20005e-05
|
|
|
GDF5
|
[NCBI]
|
1.18959e-05
|
|
|
KCNH2
|
[NCBI]
|
1.1798e-05
|
|
|
EPO
|
[NCBI]
|
1.16703e-05
|
|
|
ALDH2
|
[NCBI]
|
1.15956e-05
|
|
|
FANCA
|
[NCBI]
|
1.15956e-05
|
|
|
SLC26A4
|
[NCBI]
|
1.15956e-05
|
|
|
PPT1
|
[NCBI]
|
1.13114e-05
|
|
|
HSCR1
|
[NCBI]
|
1.12067e-05
|
|
|
ATP7B
|
[NCBI]
|
1.11748e-05
|
|
|
GAA
|
[NCBI]
|
1.10417e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
1.09335e-05
|
|
|
VMD
|
[NCBI]
|
1.09335e-05
|
|
|
MJD
|
[NCBI]
|
1.08392e-05
|
|
|
LPA
|
[NCBI]
|
1.07852e-05
|
|
|
APOB
|
[NCBI]
|
1.07571e-05
|
|
|
MAFD6
|
[NCBI]
|
1.06695e-05
|
|
|
POLG
|
[NCBI]
|
1.06615e-05
|
|
|
DM2
|
[NCBI]
|
1.06008e-05
|
|
|
KAL1
|
[NCBI]
|
1.05407e-05
|
|
|
FMF
|
[NCBI]
|
1.04813e-05
|
|
|
MTATP6
|
[NCBI]
|
1.04227e-05
|
|
|
TNFRSF6
|
[NCBI]
|
1.03073e-05
|
|
|
SCS
|
[NCBI]
|
1.02787e-05
|
|
|
aortic valve disease
|
[NCBI]
|
1.02787e-05
|
|
|
COL7A1
|
[NCBI]
|
1.01944e-05
|
|
|
FGF23
|
[NCBI]
|
1.00839e-05
|
|
|
NTRK1
|
[NCBI]
|
1.00839e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
9.96664e-06
|
|
|
SCA6
|
[NCBI]
|
9.96664e-06
|
|
|
SH2D1A
|
[NCBI]
|
9.86995e-06
|
|
|
HBA1
|
[NCBI]
|
9.78233e-06
|
|
|
CYP2D6
|
[NCBI]
|
9.76623e-06
|
|
|
GHR
|
[NCBI]
|
9.74751e-06
|
|
|
RTT
|
[NCBI]
|
9.74409e-06
|
|
|
GALT
|
[NCBI]
|
9.6646e-06
|
|
|
UNG
|
[NCBI]
|
9.6646e-06
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
9.66431e-06
|
|
|
LHCGR
|
[NCBI]
|
9.56497e-06
|
|
|
PLP1
|
[NCBI]
|
9.37144e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
9.37125e-06
|
|
|
BRRS
|
[NCBI]
|
9.37125e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
9.37125e-06
|
|
|
DRD2
|
[NCBI]
|
9.2774e-06
|
|
|
PSEN2
|
[NCBI]
|
9.2774e-06
|
|
|
RPGR
|
[NCBI]
|
9.1851e-06
|
|
|
CDH1
|
[NCBI]
|
9.0055e-06
|
|
|
WT1
|
[NCBI]
|
8.91808e-06
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
8.84422e-06
|
|
|
CCM
|
[NCBI]
|
8.81142e-06
|
|
|
MHS1
|
[NCBI]
|
8.81142e-06
|
|
|
UGT1A1
|
[NCBI]
|
8.66479e-06
|
|
|
FOXP3
|
[NCBI]
|
8.58319e-06
|
|
|
BIRC1
|
[NCBI]
|
8.58319e-06
|
|
|
CTNNB1
|
[NCBI]
|
8.34631e-06
|
|
|
CCL2
|
[NCBI]
|
8.26986e-06
|
|
|
AQP2
|
[NCBI]
|
8.19461e-06
|
|
|
THRB
|
[NCBI]
|
7.97571e-06
|
|
|
CHS
|
[NCBI]
|
7.91519e-06
|
|
|
VWS
|
[NCBI]
|
7.7875e-06
|
|
|
hurler syndrome
|
[NCBI]
|
7.7875e-06
|
|
|
MLH1
|
[NCBI]
|
7.76647e-06
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
7.54972e-06
|
|
|
MTR
|
[NCBI]
|
7.43725e-06
|
|
|
ASS
|
[NCBI]
|
7.18975e-06
|
|
|
VHL
|
[NCBI]
|
7.12991e-06
|
|
|
MKS1
|
[NCBI]
|
7.09416e-06
|
|
|
GBA
|
[NCBI]
|
6.89816e-06
|
|
|
MPZ
|
[NCBI]
|
6.67779e-06
|
|
|
GCK
|
[NCBI]
|
6.67779e-06
|
|
|
TCOF
|
[NCBI]
|
6.66374e-06
|
|
|
homocystinuria
|
[NCBI]
|
6.62436e-06
|
|
|
GUSB
|
[NCBI]
|
6.07615e-06
|
|
|
porphyria variegata
|
[NCBI]
|
6.06157e-06
|
|
|
CHH
|
[NCBI]
|
6.06157e-06
|
|
|
TD1
|
[NCBI]
|
6.06157e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
6.06157e-06
|
|
|
EGFR
|
[NCBI]
|
5.93138e-06
|
|
|
IFNA1
|
[NCBI]
|
5.80431e-06
|
|
|
COL1A1
|
[NCBI]
|
5.59057e-06
|
|
|
GFAP
|
[NCBI]
|
5.40181e-06
|
|
|
EKD1
|
[NCBI]
|
5.30231e-06
|
|
|
FTD
|
[NCBI]
|
5.16514e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
5.1619e-06
|
|
|
HBA2
|
[NCBI]
|
5.04588e-06
|
|
|
RET
|
[NCBI]
|
4.97385e-06
|
|
|
IBD1
|
[NCBI]
|
4.67769e-06
|
|
|
PSACH
|
[NCBI]
|
4.67769e-06
|
|
|
GC
|
[NCBI]
|
4.44192e-06
|
|
|
HMBS
|
[NCBI]
|
4.41107e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
4.37586e-06
|
|
|
SCA2
|
[NCBI]
|
4.37586e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
4.23088e-06
|
|
|
WAS
|
[NCBI]
|
4.16033e-06
|
|
|
CCD
|
[NCBI]
|
4.08971e-06
|
|
|
PSEN1
|
[NCBI]
|
3.89704e-06
|
|
|
APP
|
[NCBI]
|
3.64151e-06
|
|
|
NPPA
|
[NCBI]
|
3.5787e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
3.56118e-06
|
|
|
CDK4
|
[NCBI]
|
3.47376e-06
|
|
|
BLM
|
[NCBI]
|
3.43762e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.43762e-06
|
|
|
LS
|
[NCBI]
|
3.43762e-06
|
|
|
IHH
|
[NCBI]
|
3.40447e-06
|
|
|
WRN
|
[NCBI]
|
3.31731e-06
|
|
|
PEDF
|
[NCBI]
|
3.20538e-06
|
|
|
EPOR
|
[NCBI]
|
3.16284e-06
|
|
|
PMP22
|
[NCBI]
|
3.14179e-06
|
|
|
COMP
|
[NCBI]
|
2.91963e-06
|
|
|
AR
|
[NCBI]
|
2.86674e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
2.55977e-06
|
|
|
PD
|
[NCBI]
|
2.45756e-06
|
|
|
RB1
|
[NCBI]
|
2.42268e-06
|
|
|
SRS
|
[NCBI]
|
2.33149e-06
|
|
|
IDDM
|
[NCBI]
|
2.33149e-06
|
|
|
FFI
|
[NCBI]
|
2.01607e-06
|
|
|
APOE
|
[NCBI]
|
1.95587e-06
|
|
|
SCA1
|
[NCBI]
|
1.85415e-06
|
|
|
TTR
|
[NCBI]
|
1.79971e-06
|
|
|
SCZD
|
[NCBI]
|
1.42086e-06
|
|
|
CD
|
[NCBI]
|
1.2793e-06
|
|
|
SLC6A4
|
[NCBI]
|
1.25476e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.23159e-06
|
|
|
LPL
|
[NCBI]
|
1.18079e-06
|
|
|
MAG
|
[NCBI]
|
8.63007e-07
|
|
|
EV
|
[NCBI]
|
8.53898e-07
|
|
|
MS
|
[NCBI]
|
8.53898e-07
|
|
|
ADA
|
[NCBI]
|
5.99532e-07
|
|
|
HP
|
[NCBI]
|
3.98194e-07
|
|
|
ACE
|
[NCBI]
|
3.82072e-07
|
|
|
APC
|
[NCBI]
|
3.22073e-07
|
|
|
leber optic atrophy
|
[NCBI]
|
3.18486e-07
|
|
|
DGS
|
[NCBI]
|
2.20288e-07
|
|
|
ALD
|
[NCBI]
|
1.61411e-07
|
|
|
HBB
|
[NCBI]
|
1.56199e-07
|
|
|
GAPDH
|
[NCBI]
|
9.61246e-08
|
|
|
polycystic kidneys
|
[NCBI]
|
9.14624e-08
|
|
|
SOD2
|
[NCBI]
|
8.5177e-08
|
|
|
CMM
|
[NCBI]
|
7.68382e-08
|
|
|
SMAX1
|
[NCBI]
|
6.37298e-08
|
|
|
HD
|
[NCBI]
|
2.03824e-08
|
|
|
XDH
|
[NCBI]
|
2.00922e-09
|
|
|
COMT
|
[NCBI]
|
1.03055e-09
|
|
|
AT
|
[NCBI]
|
3.76427e-10
|
|